Cardiologist, Multi-modality imaging HIBA. Fellowship in research heart valve disease. IUCPQ – PhD student. Université Laval.🇦🇷🇨🇦
Québec, Canada
Joined July 2020
- Tweets76
- Following438
- Followers358
- Likes1.3K
Antonela Zanuttini retweeted
🚨Our last publication. Emerging biomarker, Human Epididymis Protein 4 in Transcatheter Aortic Valve Implantation: Diagnostic and Prognostic Value | JACC: Advances jacc.org/doi/10.1016/j.jacad…
Great job!
Antonela Zanuttini retweeted
🚨Our last manuscrit @SpringerCurRpts
Prosthesis-Patient Mismatch: Current State of Evidence.
@AMZanuttini @SbastienHecht1 @TernacleJ @PPibarot
Take a look at the article! link.springer.com/10.1007/s1…
Antonela Zanuttini retweeted
Just presented at TCT and published in NEJM by @PhilGenereuxMD showing superiority of early TAVR in asymptomatic
severe AS. This trial will change the guidelines !
Antonela Zanuttini retweeted
This #WorldHeartDay, USE ❤️ FOR ACTION.
Cardiovascular disease remains the world's biggest killer. To change this, we're asking everyone to send a message to our leaders.
Visit worldheartday.org/petition and sign our petition to prioritize heart health. #UseHeart #HeartYes
Antonela Zanuttini retweeted
Asymptomatic Severe AS: LBCT @TCTConference 2024 includes Early TAVR and EVOLVED. See recent AVATAR Trial F/U bit.ly/AVATAR_FU @TCTMD @PPibarot @djc795 @ACCinTouch @escardio @ESC_Journals @NEJM
Antonela Zanuttini retweeted
My main takeaway from RHEIA:
The first ever RCT only including women sets the scene for TAVI being the default strategy in female<75 with severe AS🔥🔥! Better access, short hospital stay, faster recovery + excellent clinical and echo outcomes.
Antonela Zanuttini retweeted
Today we presented the results of the RHEIA trial at ESC in London. This is the very first RCT transcatheter therapy that is dedicated to women. TAVR was superior to SAVR for the PE of mortality, stroke and rehospitalization.
Antonela Zanuttini retweeted
This comprehensive review examines the durability of transcatheter aortic valve implantation (#TAVI) compared to surgical aortic valve replacement (SAVR). It suggests that TAVI valves show similar midterm durability to SAVR, with low rates of valve failure at 5-10 years. However, more long-term data are needed to confirm these results, especially in younger, low-risk populations.@TernacleJ @PPibarot #TAVIdurability
ow.ly/uXZS50SBTC9
Antonela Zanuttini retweeted
🆕 State of the Art
DURABILITY OF TRANSCATHETER AORTIC VALVE IMPLANTATION
TAVI shows promising long-term results, comparable to SAVR, even in younger, low-risk patients. @PPibarot #Cardiology #EAPCI #TAVI #SAVR
ow.ly/LCJn50SBTow
Antonela Zanuttini retweeted
How to standardize and harmonize echo core labs: a collaboration between IUCPQ and Cardialysis core labs. @IUCPQ @spitzertweets
Echocardiography Core Laboratory Methodology for TAVR: A Transatlantic Consensus | JACC: Cardiovascular Imaging jacc.org/doi/10.1016/j.jcmg.…
Antonela Zanuttini retweeted
Subclinical valve leaflet thrombosis following... : Current Opinion in Cardiology journals.lww.com/co-cardiolo… @AMZanuttini @erwan Salaun @ Nancy Côté @ClavelLabo @PPibarot
Antonela Zanuttini retweeted
Mitral annular disjunction (MAD) is a structural abnormality described as the distinct separation between the MV annulus, the left atrial wall & the basal portion of the inferolateral LV myocardium occurring during systole.
Read our @CASEfromASE article: bit.ly/3JxY1if
Antonela Zanuttini retweeted
Deep Dive Slides #ACC2024 on SMART Trial. @willsuh76 @PPibarot @amrabbasmd @modine_thomas @djc795 @mmamas1973 @ditchhaporia @athenapoppas NL valve w/ high gradient is NOT “dysfunction”-may be high EF! BEV EchoGradient > but CathGrad < SEV! MGrad and PPM not predictive!!
Antonela Zanuttini retweeted
Another device for aortic regurgitation with good 30 day outcomes #CRT2024. Randomized Trial coming. See also bit.ly/AR_Imaging @JACCJournals @ACCinTouch
Antonela Zanuttini retweeted
Late Breaker at #CRT24 on SESAME by Vasilis Babaliaros—some complications/deaths so not for all, more experience needed. Remodeling of septum impressive. @AdamGreenbaumMD Shout out to the Interventional Imager #echofirst @ASE360 @EACVIPresident
Antonela Zanuttini retweeted
Alain Cribier was a Giant of Cardiovascular Medicine and Innovation. He was THE pioneer of TAVI (first in man in 2002 @CHURouen). He was a great Gentleman. We will miss his vision, energy, inspiration and his smile. Rest in Peace Alain.
Antonela Zanuttini retweeted
🫀NEW GUIDELINE🫀 bit.ly/3vosxI5
We have just released "Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging," in collaboration with the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography!
Happy to share these amazing weeks at The Royal Infirmary of Edinburgh, Scotland. Very grateful for all the learning in #MRI to Dr Marc Dweck and his wonderful team, especially Dr @KrithikaLogana2!
Many thanks also to Dr @PPibarot for making it possible!
Antonela Zanuttini retweeted
Very proud to be this year again in the list of the top 1% highly cited researchers in the field of Clinical Medicine. Special thanks to my fantastic research lab team and students @IUCPQ and to all my collaborators including @ClavelLabo @hahn_rt @JoaoLCavalcante @Clarivate
